US and China clash over fentanyl and tariffs at global drugs meeting

• White House drug policy director Sara Carter accused China of manufacturing 'millions of tons' of fentanyl precursor chemicals with weak export controls that enable drug cartels
• The U.S. Supreme Court invalidated a 10% fentanyl-related tariff on China last month, but the Trump administration plans to reimpose the levy under different legal authority
• China's envoy dismissed U.S. claims as false and criticized Washington for 'unilateral bullying' and using sanctions and tariffs to 'shift blame' rather than addressing domestic drug control

Summary

Key Development: The U.S. and China exchanged sharp accusations at the U.N. Commission on Narcotic Drugs meeting in Vienna on March 9, highlighting ongoing tensions over fentanyl precursor chemicals and tariffs ahead of a high-level meeting between their leaders later this month.

Main Allegations:

• U.S. Position: Sara Carter, White House Office of National Drug Control Policy Director, accused China of manufacturing "millions of tons" of fentanyl precursor chemicals, citing weak export controls and lax enforcement that enable chemical industry ties with drug cartels.
• China's Response: Chinese envoy Gao Wei dismissed U.S. claims as false, accusing "a certain country" of using drug problems as a pretext for "unilateral bullying" and interfering in internal affairs, while criticizing the abuse of sanctions and tariffs.

Trade Agreement Context:

Under a South Korea agreement between President Trump and President Xi Jinping last year, the U.S. agreed to reduce tariffs on China in exchange for Beijing cracking down on illicit fentanyl trade, resuming soybean purchases, and maintaining rare earth exports.

Tariff Developments:

The U.S. Supreme Court recently invalidated a 10% fentanyl-related tariff Trump imposed on China. However, the Trump administration has indicated it plans to reimpose the levy under different legal authority.

Market Implications:

The dispute underscores escalating U.S.-China tensions affecting trade relations, with potential impacts on tariff policies, rare earth mineral supply chains, and agricultural exports. The upcoming leader meeting could prove critical for resolving these issues.